Establishing hemolysis, icterus, and lipemia interference limits for body fluid chemistry analytes measured on the Roche cobas instrument.

MLA

Block, Darci R., et al. “Establishing Hemolysis, Icterus, and Lipemia Interference Limits for Body Fluid Chemistry Analytes Measured on the Roche Cobas Instrument.” American Journal of Clinical Pathology, vol. 162, no. 4, Oct. 2024, pp. 356–68. EBSCOhost, https://doi.org/10.1093/ajcp/aqae040.

APA

Block, D. R., Lasho, M. A., Donato, L. J., & Meeusen, J. W. (2024). Establishing hemolysis, icterus, and lipemia interference limits for body fluid chemistry analytes measured on the Roche cobas instrument. American Journal of Clinical Pathology, 162(4), 356–368. https://doi.org/10.1093/ajcp/aqae040

Chicago

Block, Darci R, Michael A Lasho, Leslie J Donato, and Jeffrey W Meeusen. 2024. “Establishing Hemolysis, Icterus, and Lipemia Interference Limits for Body Fluid Chemistry Analytes Measured on the Roche Cobas Instrument.” American Journal of Clinical Pathology 162 (4): 356–68. doi:10.1093/ajcp/aqae040.